We found that plasma MPO concentration was genetically associated with increased risks of respiratory infections (URTI: OR = 1.135, 95% CI = 1.011–1.274, P=0.032; LRTI in the critical care units: OR = 1.323, 95% CI = 1.006–1.739, P=0.045). Here, MPO is linked to respiratory tract infectious disorder.